First documented in ancient Egypt in 1 500 B.C., diabetes is one of the most serious and critical global health problems in the 21st century. It may induce many complications, such as cardiovascular and cerebrovascular diseases, neuropathy, pedopathy, nephropathy, and retinopathy. Exacerbated diabetes can be life-threatening and seriously affect the growth and development of children. However, there is no cure for diabetes at present. Therapeutic approaches for diabetes mainly include oral hypoglycemic agents, insulin injections, and diet control, with the general principle of controlling blood glucose and preventing complications via lifestyle alterations (e.g., diet control, physical exercise and weight loss) combined with certain medications. Despite the rapid advances in modern technology and medical level, the action mechanisms of many therapeutic agents against diabetes remain unclear. The scientificity and effectiveness of many therapeutic methods need to be verified, and the nursing support methods for diabetic patients with complications need to be improved. In these fields, Chinese researchers, who have been committed to revealing the mechanisms of diabetes medications and improving the therapy and care of diabetic patients, have profoundly contributed to the treatment and rehabilitation of diabetic patients.
Since 2014, Acta Pharmaceutica Sinica, The Chinese Journal of Clinical Pharmacology, Chinese Pharmacological Bulletin, Chinese Pharmaceutical Journal and Chinese Journal of Nursing have joined the Journal Translation Project (JTP, http://jtp.cnki.net/bilingual). By 2020, 1 330 articles from these journals have been selected for JTP and published in both Chinese and English, which has enhanced the international influence of these journals. In order to strengthen the international dissemination of these journals and make more readers aware of the latest research progress in treatment of diabetes by using western medical approaches in China, China National Knowledge Infrastructure (CNKI) and the editorial boards of these journals organized experts to choose 27 research articles regarding the application of western medical approaches in the treatment and care of diabetes. These articles are compiled into Diabetes (Western Medicine) (English edition), which is part of the China’s Medicine Progress Series (English edition). The included articles are recommended by the editorial boards of the journals in which they were first published, covering mechanism, clinical, and nursing studies and fully demonstrating the cutting-edge progress in the treatment of diabetes in China, with scientific methodological support and objective conclusions. The original papers were published in Chinese, and this book is a compilation of selections in English version.
As the editor-in-chief of this book, I believe that this book can provide effective experience and methods from Chinese medical and pharmaceutical community to global therapy and care for diabetic patients, as well as scientific, practical, and up-to-date literature for the medical and pharmaceutical professionals from all over the world. This book will enhance the international influence of these journals.
Editor-in-chief: JIANG Xiaoying收起